EcoDrugPlus

60s Ribosomal Protein L18

Ensembl ID : ENSSSAG00000002140
Gene Symbol: LOC106577306
4 Cross references
374 Possible Orthologues:

60s Ribosomal Protein L18a

Ensembl ID : ENSSSAG00000061643
Gene Symbol: LOC123731929
3 Cross references
347 Possible Orthologues:

60s Ribosomal Protein L19

Ensembl ID : ENSSSAG00000044188
Gene Symbol: RL19
4 Cross references
345 Possible Orthologues:

60s Ribosomal Protein L24

Ensembl ID : ENSSSAG00000068449
Gene Symbol: LOC106586748
4 Cross references
311 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSSSAG00000076707
Gene Symbol: RL26
4 Cross references
472 Possible Orthologues:

60s Ribosomal Protein L28

Ensembl ID : ENSSSAG00000039626
Gene Symbol: RL28
4 Cross references
278 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSSSAG00000066053
Gene Symbol: LOC106589133
5 Cross references
409 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSSSAG00000014512
Gene Symbol: LOC106597426
3 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L30-Like

Ensembl ID : ENSSSAG00000104893
Gene Symbol: LOC106597426
4 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L31

Ensembl ID : ENSSSAG00000118024
Gene Symbol: LOC106574971
4 Cross references
563 Possible Orthologues:

60s Ribosomal Protein L31

Ensembl ID : ENSSSAG00000057006
Gene Symbol: LOC106582252
4 Cross references
72 Possible Orthologues:

60s Ribosomal Protein L36

Ensembl ID : ENSSSAG00000075425
Gene Symbol: LOC106583952
4 Cross references
362 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).